Legg Mason Asset Management Japan Co. Ltd. acquired a new position in Chemours Company (The) (NYSE:CC) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 18,400 shares of the specialty chemicals company’s stock, valued at approximately $698,000.

Several other large investors have also added to or reduced their stakes in the company. Bayesian Capital Management LP acquired a new stake in shares of Chemours Company (The) in the second quarter worth $296,000. Zacks Investment Management grew its position in Chemours Company (The) by 1.6% during the second quarter. Zacks Investment Management now owns 62,894 shares of the specialty chemicals company’s stock valued at $2,385,000 after buying an additional 973 shares during the period. OxFORD Asset Management LLP acquired a new stake in Chemours Company (The) during the second quarter valued at $9,961,000. Virtu KCG Holdings LLC grew its position in Chemours Company (The) by 1,274.5% during the second quarter. Virtu KCG Holdings LLC now owns 82,500 shares of the specialty chemicals company’s stock valued at $3,128,000 after buying an additional 76,498 shares during the period. Finally, Renaissance Technologies LLC grew its position in Chemours Company (The) by 10.3% during the second quarter. Renaissance Technologies LLC now owns 3,342,200 shares of the specialty chemicals company’s stock valued at $126,736,000 after buying an additional 310,800 shares during the period. Hedge funds and other institutional investors own 72.90% of the company’s stock.

In other news, insider E Bryan Snell sold 13,000 shares of the company’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $49.35, for a total transaction of $641,550.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP David C. Shelton sold 13,337 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $48.48, for a total transaction of $646,577.76. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 38,837 shares of company stock worth $1,865,603. Corporate insiders own 1.14% of the company’s stock.

Several analysts recently commented on the stock. UBS AG restated a “sell” rating and set a $36.00 price target (up previously from $35.00) on shares of Chemours Company (The) in a research report on Wednesday, June 14th. Zacks Investment Research lowered shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a research report on Wednesday, July 12th. J P Morgan Chase & Co raised their price target on shares of Chemours Company (The) to $55.00 and gave the company an “overweight” rating in a research report on Friday, August 4th. Jefferies Group LLC restated a “buy” rating and set a $50.00 price target (up previously from $48.00) on shares of Chemours Company (The) in a research report on Thursday, July 13th. Finally, BidaskClub upgraded shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a research report on Wednesday, July 12th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $51.50.

WARNING: This piece was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/28/legg-mason-asset-management-japan-co-ltd-invests-698000-in-chemours-company-the-cc.html.

Shares of Chemours Company (NYSE CC) traded down 0.208% during mid-day trading on Thursday, hitting $50.385. 135,716 shares of the stock traded hands. The firm’s 50 day moving average price is $50.42 and its 200 day moving average price is $50.42. Chemours Company has a 12-month low of $14.41 and a 12-month high of $52.15. The firm has a market cap of $9.31 billion, a price-to-earnings ratio of 32.974 and a beta of 3.64.

Chemours Company (The) (NYSE:CC) last posted its quarterly earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.85 by $0.02. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.49 billion. During the same period in the prior year, the company posted $0.27 EPS. The business’s revenue for the quarter was up 14.8% on a year-over-year basis. On average, equities research analysts predict that Chemours Company will post $3.51 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Thursday, August 17th were paid a dividend of $0.03 per share. The ex-dividend date was Tuesday, August 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.24%. Chemours Company (The)’s dividend payout ratio (DPR) is presently 8.11%.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Stock Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related stocks with our FREE daily email newsletter.